Linear basic compounds having NK-2 antagonist activity and formulations thereof
US7273856B2 · kind B2 · utility
6Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2002 |
| Grant date | Sep 25, 2007 |
| Priority date | — |
| Expiry date | Oct 28, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.